Allstate Corp Has $2.58 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Allstate Corp raised its holdings in HCA Healthcare, Inc. by 29.6% during the first quarter, bringing its total value to approximately $2.58 million.
• HCA Healthcare announced a quarterly dividend of $0.72 to be paid on September 30, with an annualized yield of 0.7%.
• Recent analyst ratings for HCA Healthcare include a mix of upgrades and price target adjustments, with a consensus rating of "Moderate Buy" and an average target price of $398.58.

Allstate Corp lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 29.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,452 shares of the company's stock after acquiring an additional 1,701 shares during the quarter. Allstate Corp's holdings in HCA Healthcare were worth $2,575,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the stock. Gitterman Wealth Management LLC acquired a new position in shares of HCA Healthcare during the first quarter valued at approximately $431,000. Compound Planning Inc. acquired a new position in HCA Healthcare in the first quarter worth approximately $320,000. Ameriprise Financial Inc. grew its position in HCA Healthcare by 10.2% in the first quarter. Ameriprise Financial Inc. now owns 483,564 shares of the company's stock worth $167,094,000 after buying an additional 44,884 shares during the last quarter. Norinchukin Bank The grew its position in HCA Healthcare by 10.7% in the first quarter. Norinchukin Bank The now owns 7,966 shares of the company's stock worth $2,753,000 after buying an additional 770 shares during the last quarter. Finally, CW Advisors LLC grew its position in HCA Healthcare by 22.9% in the first quarter. CW Advisors LLC now owns 1,277 shares of the company's stock worth $441,000 after buying an additional 238 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Trading Down 0.3%

NYSE:HCA traded down $1.05 during trading hours on Tuesday, hitting $401.72. The stock had a trading volume of 1,180,566 shares, compared to its average volume of 1,561,315. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The company has a market cap of $94.00 billion, a price-to-earnings ratio of 16.89, a P/E/G ratio of 1.27 and a beta of 1.39. The business's 50 day moving average is $374.60 and its 200-day moving average is $354.80.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm's revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is currently 12.11%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on HCA shares. Robert W. Baird lifted their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research report on Thursday, August 14th. Barclays decreased their target price on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a research note on Monday, July 28th. Wolfe Research lowered shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Bank of America lowered shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective for the company. in a research note on Wednesday, July 16th. Finally, Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $401.83.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.